Distributed by Merck & Co., Dolobid® (generically referred to as Diflunisal) is a nonsteroidal anti-inflammatory drug (NSAID) that is prescribed for the treatment of rheumatoid arthritis, osteoarthritis and/or any type of mild to moderate chronic pain (especially that resulting from dental surgery). Dolobid® comes in tablet form. It was first approved by the U.S. Food and Drug Administration (FDA) in April 1982.
Dolobid® is allegedly linked to a number of severe, life-threatening side effects, including heart attack, stroke and Stevens-Johnson syndrome (SJS). If you or a loved one has developed SJS and has a history of taking Dolobid® or any type of NSAID, you may be able to seek and recover compensation for your injuries and losses. To find out more information contact our legal offices today.
Some of the more minor side effects of Dolobid® may include diarrhea, dizziness, gas, heartburn, upset stomach, nausea and more.
Stevens-Johnson syndrome is an extremely serious skin condition in which the top layer of a person's skin (epidermis) detaches from the middle layer of skin (dermis), thereby causing the death of the skin cells. In addition to this painful symptom, Stevens-Johnson syndrome patients may experience flu-like symptom and painful sores in the mucous membranes of the mouth, nose and eyes.
When the rash affects more than 30 percent of a patient's body, the condition is classified as toxic epidermal necrosis (TENS) - which is far more serious form of the same condition.
Upon an SJS or TENS diagnosis, patients are immediately transferred to an intensive care unit (ICU) or a burn unit where they are administered corticosteroids, intravenous fluids and, when infections are present, antibiotic drugs. Patients with the best prognosis will be those who catch and treat the condition in its earliest stages.
Find out patient resources. We may be able to help you seek out a financial recovery for the losses you incurred as a result of your condition.